Therapeutic effects of Qiliqiangxin capsule on chronic heart failure patients with renal insufficiency
Kaili Yan
Abstract
Kaili Yan
Abstract
Objective To investigate the therapeutic effects of Qiliqiangxin capsule on chronic heart failure(CHF) patients with renal insufficiency.Methods A total of 120 CHF patients with renal insufficiency were randomly divided into Qiliqiangxin capsule therapy group(n =60,received Qiliqiangxin capsule on routine heart failure therapy for 12 weeks) and control group(n =60,received routine therapy alone for 12 weeks).Results After treatment,there were significant increase in NYHA grading,LVEF and CO and there were significant decrease in LVEDD in both groups(P 0.05).Compared with control group,there were significant improvement of NYHA grading,LVEF and CO in therapy group(P 0.05). No significant difference in LVEDD could be found between the two groups(P 0.05).The rate of poisoning by digoxin in therapy group was lower than that of control group(P 0.05).Conclusion Qiliqiangxin capsule can significantly improve heart function,decrease the rate of poisoning by digoxin,increase therapeutic effects in CHF with renal insufficiency.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the therapeutic effects of Qiliqiangxin capsule on chronic heart failure(CHF) patients with renal insufficiency.Methods A total of 120 CHF patients with renal insufficiency were randomly divided into Qiliqiangxin capsule therapy group(n =60,received Qiliqiangxin capsule on routine heart failure therapy for 12 weeks) and control group(n =60,received routine therapy alone for 12 weeks).Results After treatment,there were significant increase in NYHA grading,LVEF and CO and there were significant decrease in LVEDD in both groups(P 0.05).Compared with control group,there were significant improvement of NYHA grading,LVEF and CO in therapy group(P 0.05). No significant difference in LVEDD could be found between the two groups(P 0.05).The rate of poisoning by digoxin in therapy group was lower than that of control group(P 0.05).Conclusion Qiliqiangxin capsule can significantly improve heart function,decrease the rate of poisoning by digoxin,increase therapeutic effects in CHF with renal insufficiency.
Key concepts: Medicine, Digoxin, Capsule, Ejection fraction, Heart failure, Internal medicine, Therapeutic effect, Cardiology